July 8, 2026 · Form 4 insider transaction
Lin Liwei Lorraine bought 254,780 shares of NovaBridge Biosciences at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Number of underlying securities and exercise price expressed in terms of American Depositary Shares ("ADS").; The option vests and becomes exercisable over five years, with 40% vesting on the second anniversary of February 1, 2026 and the balance vesting in three equal annual installments thereafter.; The Ordinary Shares may be represented by ADSs. Each 10 ADSs represent 23 Ordinary Shares of the Issuer.